Cancer development and progression occurs in concert with alterations in the surrounding stroma. Cancer cells can functionally sculpt their microenvironment through the secretion of various cytokines, chemokines, and other factors. This results in a reprogramming of the surrounding cells, enabling them to play a determinative role in tumor survival and progression. Immune cells are important constituents of the tumor stroma and critically take part in this process. Growing evidence suggests that the innate immune cells (macrophages, neutrophils, dendritic cells, innate lymphoid cells, myeloid-derived suppressor cells, and natural killer cells) as well as adaptive immune cells (T cells and B cells) contribute to tumor progression when present in the tumor microenvironment (TME). Cross-talk between cancer cells and the proximal immune cells ultimately results in an environment that fosters tumor growth and metastasis. Understanding the nature of this dialog will allow for improved therapeutics that simultaneously target multiple components of the TME, increasing the likelihood of favorable patient outcomes.
©2019 American Association for Cancer Research.
Conflict of interest statement
Conflict of Interest:
The authors have no conflict of interest to disclose.
Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy.Front Oncol. 2018 Aug 13;8:284. doi: 10.3389/fonc.2018.00284. eCollection 2018. Front Oncol. 2018. PMID: 30151352 Free PMC article. Review.
Immune Suppression Mediated by Myeloid and Lymphoid Derived Immune Cells in the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by HrasG12V and Pten Loss.J Clin Cell Immunol. 2016 Oct;7(5):451. doi: 10.4172/2155-9899.1000451. Epub 2016 Sep 16. J Clin Cell Immunol. 2016. PMID: 27942419 Free PMC article.
[Strategical consideration of the interaction between tumor microenvironment and tumor immunity].Rinsho Ketsueki. 2018;59(10):1895-1904. doi: 10.11406/rinketsu.59.1895. Rinsho Ketsueki. 2018. PMID: 30305490 Review. Japanese.
Myeloid regulatory cells in tumor spreading and metastasis.Immunobiology. 2015 Feb;220(2):236-42. doi: 10.1016/j.imbio.2014.07.017. Epub 2014 Jul 23. Immunobiology. 2015. PMID: 25178934 Review.
The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas.Front Oncol. 2018 May 8;8:147. doi: 10.3389/fonc.2018.00147. eCollection 2018. Front Oncol. 2018. PMID: 29868471 Free PMC article. Review.
Cited by 9 articles
Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies.Theranostics. 2020 Feb 10;10(7):3099-3117. doi: 10.7150/thno.42998. eCollection 2020. Theranostics. 2020. PMID: 32194857 Free PMC article. Review.
Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies.Cancers (Basel). 2020 Feb 8;12(2):392. doi: 10.3390/cancers12020392. Cancers (Basel). 2020. PMID: 32046278 Free PMC article. Review.
Coordinated signals from PARP-1 and PARP-2 are required to establish a proper T cell immune response to breast tumors in mice.Oncogene. 2020 Mar;39(13):2835-2843. doi: 10.1038/s41388-020-1175-x. Epub 2020 Jan 30. Oncogene. 2020. PMID: 32001817
Exosomes in Bone Sarcomas: Key Players in Metastasis.Cells. 2020 Jan 17;9(1):241. doi: 10.3390/cells9010241. Cells. 2020. PMID: 31963599 Free PMC article. Review.
Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses.Cells. 2019 Dec 23;9(1):46. doi: 10.3390/cells9010046. Cells. 2019. PMID: 31878087 Free PMC article. Review.